The average one-year price target for Viatris (BIT:1VTRS) has been revised to €17.71 / share. This is an increase of 10.11% from the prior estimate of €16.08 dated September 13, 2026. These figures ...
The average one-year price target for Robinhood Markets (BMV:HOOD) has been revised to MX$2,483.99 per share. This represents an increase of 10.55% from the prior estimate of MX$2,247.01 dated ...
INDICATION AUCATZYL ® is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...
Nearly €215B of French investment-grade corporate bonds yield less than comparable government debt amid sovereign concerns ...
CSPC Pharma announced that the group has presented, in the form of a rapid oral presentation at the 2026 International ...
Initial Phase 1b data highlight promising clinical activity in patients with PROC and support continued clinical development of CUSP06At the ...
Record online holiday spending and solid in-store traffic could boost Amazon and 2 fundamentally strong retail stocks. Click ...
Erasca is now a fully funded fast follower in RAS-targeted oncology, with ~$1B pro forma liquidity and three potential ...
Newsable Asianet News on MSN
SpaceX Could Help Create ‘Millions’ Of Jobs, Morgan Stanley Says – Here’s What Its Next Chapter Looks Like
Morgan Stanley said the next chapter of the SpaceX story is its role in converting energy into intelligence through physical ...
The WCLC 2026 conference saw updates on new antibody-drug conjugates and treatment protocols for small cell and non-small ...
August–September 2026 / bladder cancer, cancer, cancer care, Cancer research, cancer treatment, chemotherapy, clinical trials ...
The pain is in my hip, though.”When your hip hurts, and you are asked about things other than the pain, I think it’s natural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results